AC Immune (ACIU) Change in Accured Expenses (2017 - 2025)
AC Immune has reported Change in Accured Expenses over the past 9 years, most recently at -$4.7 million for Q4 2025.
- Quarterly Change in Accured Expenses fell 328.95% to -$4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.7 million through Dec 2025, down 407.74% year-over-year, with the annual reading at -$4.8 million for FY2025, 408.22% down from the prior year.
- Change in Accured Expenses was -$4.7 million for Q4 2025 at AC Immune, down from $645056.5 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $3.3 million in Q4 2021 and troughed at -$5.6 million in Q1 2022.
- The 5-year median for Change in Accured Expenses is $399811.7 (2025), against an average of -$55722.4.
- Year-over-year, Change in Accured Expenses skyrocketed 4222.27% in 2021 and then crashed 3746.87% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $3.3 million in 2021, then plummeted by 83.23% to $561217.5 in 2022, then skyrocketed by 148.08% to $1.4 million in 2023, then tumbled by 178.71% to -$1.1 million in 2024, then tumbled by 328.95% to -$4.7 million in 2025.
- Per Business Quant, the three most recent readings for ACIU's Change in Accured Expenses are -$4.7 million (Q4 2025), $645056.5 (Q3 2025), and $399811.7 (Q2 2025).